Yes, the Movn program is a full-service program that includes the software, providers and technology. You can simply refer your patients and we will take care of the rest.
The Movn program is intended for patients who can safely exercise independently at home. We typically enroll low-to-moderate risk patients and in some cases, high-risk patients if they are cleared by their provider.
Multiple studies show that guided home exercise is safe for appropriate patients, and rates of adverse events are low. We help patients and their caregivers understand their individual exercise prescription and what to do in case of emergency.
Our clinical content/protocols were built in collaboration with Stanford Medicine, have been validated on over 70,000 patients and showed the following outcomes in a peer reviewed study
The ROI for the Movn program depends on the stakeholder.
For health plans, Movn is less expensive to deliver than in-person cardiac rehab. Patients who enroll in our program have a lower readmission reduction rate (10 – 15%) at 12 months compared to patients who do not participate in rehab (30 – 50%).
For Providers:
The Movn program is offered at no cost to the organization because it is covered by several health plans. Providers do not have to have their own cardiac rehab staff to deliver the program. They can simply refer their patients to Movn. The Movn program requires no real estate or staffing to implement and can be implemented in a few days.
For Patients:
The Mpvn program is more convenient, accessible, affordable and personalized than in-person rehab.
We work with most of our health plan partners to waive co-pays for Movn, so the program is more affordable.
The Movn team consists of cardiologists, nurses, exercise physiologists and nutritionists who deliver the program. We also have our own in-house customer support and technology assistance team.
Yes
We support the major EMRs including EPIC, Cerner and Allscripts.
Yes
Yes.
The Movn program is designed for patients with coronary artery disease (CAD) and heart failure.